Phosphodiesterase 11: a brief review of structure, expression and function (Q36361603)

13 August 2017

1 reference

title

Phosphodiesterase 11: a brief review of structure, expression and function (English)

1 reference

13 August 2017

Makhlouf A

1

1 reference

13 August 2017

Kshirsagar A

series ordinal

2

1 reference

13 August 2017

Niederberger C

series ordinal

3

1 reference

13 August 2017

publication date

5 January 2006

1 reference

International Journal of Impotence Research

13 August 2017

published in

1 reference

13 August 2017

volume

18

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

501-509

1 reference

Phosphodiesterases as therapeutic targets

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Potency, selectivity, and consequences of nonselectivity of PDE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Cyclic nucleotide phosphodiesterases in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Cloning and characterization of two splice variants of human phosphodiesterase 11A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

PDE5 is converted to an activated state upon cGMP binding to the GAF A domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Vardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Expression of PDE11A in normal and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Capacitation as a regulatory event that primes spermatozoa for the acrosome reaction and fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

Specific expression of soluble adenylyl cyclase in male germ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901441

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJIR.3901441

1 reference

13 August 2017

1 reference